Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the Clinic.

Salvucci M, Rahman A, Resler AJ, Udupi GM, McNamara DA, Kay EW, Laurent-Puig P, Longley DB, Johnston PG, Lawler M, Wilson R, Salto-Tellez M, Van Schaeybroeck S, Rafferty M, Gallagher WM, Rehm M, Prehn JHM.

JCO Clin Cancer Inform. 2019 Apr;3:1-17. doi: 10.1200/CCI.18.00056.

2.

Simulating and predicting cellular and in vivo responses of colon cancer to combined treatment with chemotherapy and IAP antagonist Birinapant/TL32711.

Crawford N, Salvucci M, Hellwig CT, Lincoln FA, Mooney RE, O'Connor CL, Prehn JH, Longley DB, Rehm M.

Cell Death Differ. 2018 Nov;25(11):1952-1966. doi: 10.1038/s41418-018-0082-y. Epub 2018 Mar 2.

3.

Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.

Efficace F, Castagnetti F, Martino B, Breccia M, D'Adda M, Angelucci E, Stagno F, Cottone F, Malato A, Trabacchi E, Capalbo SF, Gobbi M, Visani G, Salvucci M, Capodanno I, Tosi P, Tiribelli M, Scortechini AR, Levato L, Maino E, Binotto G, Gugliotta G, Vignetti M, Baccarani M, Rosti G.

Cancer. 2018 May 15;124(10):2228-2237. doi: 10.1002/cncr.31323. Epub 2018 Mar 2.

4.

The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer.

Carberry S, D'Orsi B, Monsefi N, Salvucci M, Bacon O, Fay J, Rehm M, McNamara D, Kay EW, Prehn JHM.

Cell Death Dis. 2018 Jan 26;9(2):125. doi: 10.1038/s41419-017-0140-2.

5.

Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases.

Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, Bolaños JP, Culmsee C, Dawson VL, Deshmukh M, Duchen MR, Düssmann H, Fiskum G, Galindo MF, Hardingham GE, Hardwick JM, Jekabsons MB, Jonas EA, Jordán J, Lipton SA, Manfredi G, Mattson MP, McLaughlin B, Methner A, Murphy AN, Murphy MP, Nicholls DG, Polster BM, Pozzan T, Rizzuto R, Satrústegui J, Slack RS, Swanson RA, Swerdlow RH, Will Y, Ying Z, Joselin A, Gioran A, Moreira Pinho C, Watters O, Salvucci M, Llorente-Folch I, Park DS, Bano D, Ankarcrona M, Pizzo P, Prehn JHM.

Cell Death Differ. 2018 Mar;25(3):542-572. doi: 10.1038/s41418-017-0020-4. Epub 2017 Dec 11. Review.

6.

Lysine acetylome profiling uncovers novel histone deacetylase substrate proteins in Arabidopsis.

Hartl M, Füßl M, Boersema PJ, Jost JO, Kramer K, Bakirbas A, Sindlinger J, Plöchinger M, Leister D, Uhrig G, Moorhead GB, Cox J, Salvucci ME, Schwarzer D, Mann M, Finkemeier I.

Mol Syst Biol. 2017 Oct 23;13(10):949. doi: 10.15252/msb.20177819.

7.

Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories.

Perricone M, Palandri F, Ottaviani E, Angelini M, Bagli L, Bellesia E, Donati M, Gemmati D, Zucchini P, Mancini S, Marchica V, Trubini S, De Matteis G, Di Zacomo S, Favarato M, Fioroni A, Bolzonella C, Maccari G, Navaglia F, Gatti D, Toffolatti L, Orlandi L, Laloux V, Manfrini M, Galieni P, Giannini B, Tieghi A, Barulli S, Serino ML, Maccaferri M, Scortechini AR, Giuliani N, Vallisa D, Bonifacio M, Accorsi P, Salbe C, Fazio V, Gusella M, Toffoletti E, Salvucci M, Svaldi M, Gherlinzoni F, Cassavia F, Orsini F, Martinelli G.

Oncotarget. 2017 May 16;8(20):32608-32617. doi: 10.18632/oncotarget.15940.

8.

A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.

Castagnetti F, Di Raimondo F, De Vivo A, Spitaleri A, Gugliotta G, Fabbiano F, Capodanno I, Mannina D, Salvucci M, Antolino A, Marasca R, Musso M, Crugnola M, Impera S, Trabacchi E, Musolino C, Cavazzini F, Mineo G, Tosi P, Tomaselli C, Rizzo M, Siragusa S, Fogli M, Ragionieri R, Zironi A, Soverini S, Martinelli G, Cavo M, Vigneri P, Stagno F, Rosti G, Baccarani M.

Am J Hematol. 2017 Jan;92(1):82-87. doi: 10.1002/ajh.24591. Epub 2016 Nov 18.

9.

BCL-2 system analysis identifies high-risk colorectal cancer patients.

Lindner AU, Salvucci M, Morgan C, Monsefi N, Resler AJ, Cremona M, Curry S, Toomey S, O'Byrne R, Bacon O, Stühler M, Flanagan L, Wilson R, Johnston PG, Salto-Tellez M, Camilleri-Broët S, McNamara DA, Kay EW, Hennessy BT, Laurent-Puig P, Van Schaeybroeck S, Prehn JHM.

Gut. 2017 Dec;66(12):2141-2148. doi: 10.1136/gutjnl-2016-312287. Epub 2016 Sep 23.

PMID:
27663504
10.

A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer.

Salvucci M, Würstle ML, Morgan C, Curry S, Cremona M, Lindner AU, Bacon O, Resler AJ, Murphy ÁC, O'Byrne R, Flanagan L, Dasgupta S, Rice N, Pilati C, Zink E, Schöller LM, Toomey S, Lawler M, Johnston PG, Wilson R, Camilleri-Broët S, Salto-Tellez M, McNamara DA, Kay EW, Laurent-Puig P, Van Schaeybroeck S, Hennessy BT, Longley DB, Rehm M, Prehn JH.

Clin Cancer Res. 2017 Mar 1;23(5):1200-1212. doi: 10.1158/1078-0432.CCR-16-1084. Epub 2016 Sep 20.

11.

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.

Castagnetti F, Breccia M, Gugliotta G, Martino B, D'Adda M, Stagno F, Carella AM, Avanzini P, Tiribelli M, Trabacchi E, Visani G, Gobbi M, Salvucci M, Levato L, Binotto G, Capalbo SF, Bochicchio MT, Soverini S, Cavo M, Martinelli G, Alimena G, Pane F, Saglio G, Rosti G, Baccarani M; GIMEMA CML Working Party.

Haematologica. 2016 Oct;101(10):1200-1207. Epub 2016 Jul 28.

12.

Heat tolerance in a wild Oryza species is attributed to maintenance of Rubisco activation by a thermally stable Rubisco activase ortholog.

Scafaro AP, Gallé A, Van Rie J, Carmo-Silva E, Salvucci ME, Atwell BJ.

New Phytol. 2016 Aug;211(3):899-911. doi: 10.1111/nph.13963. Epub 2016 May 5.

13.

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.

Soverini S, De Benedittis C, Polakova KM, Linhartova J, Castagnetti F, Gugliotta G, Papayannidis C, Mancini M, Klamova H, Salvucci M, Crugnola M, Iurlo A, Albano F, Russo D, Rosti G, Cavo M, Baccarani M, Martinelli G.

Oncotarget. 2016 Apr 19;7(16):21982-90. doi: 10.18632/oncotarget.8010.

14.

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.

Zakaria Z, Tivnan A, Flanagan L, Murray DW, Salvucci M, Stringer BW, Day BW, Boyd AW, Kögel D, Rehm M, O'Brien DF, Byrne AT, Prehn JH.

Br J Cancer. 2016 Jan 19;114(2):188-98. doi: 10.1038/bjc.2015.420. Epub 2015 Dec 10.

15.

Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia.

Gugliotta G, Castagnetti F, Breccia M, Levato L, D'Adda M, Stagno F, Tiribelli M, Salvucci M, Fava C, Martino B, Cedrone M, Bocchia M, Trabacchi E, Cavazzini F, Usala E, Russo Rossi A, Bochicchio MT, Soverini S, Alimena G, Cavo M, Pane F, Martinelli G, Saglio G, Baccarani M, Rosti G; GIMEMA CML Working Party.

Haematologica. 2015 Sep;100(9):1146-50. doi: 10.3324/haematol.2015.129221. Epub 2015 Jun 25.

16.
17.

Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement.

Soverini S, De Benedittis C, Papayannidis C, Paolini S, Venturi C, Iacobucci I, Luppi M, Bresciani P, Salvucci M, Russo D, Sica S, Orlandi E, Intermesoli T, Gozzini A, Bonifacio M, Rigolin GM, Pane F, Baccarani M, Cavo M, Martinelli G.

Cancer. 2014 Apr 1;120(7):1002-9. doi: 10.1002/cncr.28522. Epub 2013 Dec 30.

18.

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.

Efficace F, Baccarani M, Breccia M, Saussele S, Abel G, Caocci G, Guilhot F, Cocks K, Naeem A, Sprangers M, Oerlemans S, Chie W, Castagnetti F, Bombaci F, Sharf G, Cardoni A, Noens L, Pallua S, Salvucci M, Nicolatou-Galitis O, Rosti G, Mandelli F.

Qual Life Res. 2014 Apr;23(3):825-36. doi: 10.1007/s11136-013-0523-5. Epub 2013 Sep 13.

PMID:
24026634
19.

Substitutions at the opening of the Rubisco central solvent channel affect holoenzyme stability and CO2/O 2 specificity but not activation by Rubisco activase.

Esquivel MG, Genkov T, Nogueira AS, Salvucci ME, Spreitzer RJ.

Photosynth Res. 2013 Dec;118(3):209-18. doi: 10.1007/s11120-013-9916-0. Epub 2013 Sep 7.

PMID:
24014091
20.

Activation of interspecies-hybrid Rubisco enzymes to assess different models for the Rubisco-Rubisco activase interaction.

Wachter RM, Salvucci ME, Carmo-Silva AE, Barta C, Genkov T, Spreitzer RJ.

Photosynth Res. 2013 Nov;117(1-3):557-66. doi: 10.1007/s11120-013-9827-0. Epub 2013 Apr 24.

PMID:
23613007
21.

Mathematical model of metabolism and electrophysiology of amino acid and glucose stimulated insulin secretion: in vitro validation using a β-cell line.

Salvucci M, Neufeld Z, Newsholme P.

PLoS One. 2013;8(3):e52611. doi: 10.1371/journal.pone.0052611. Epub 2013 Mar 8.

22.

The regulatory properties of Rubisco activase differ among species and affect photosynthetic induction during light transitions.

Carmo-Silva AE, Salvucci ME.

Plant Physiol. 2013 Apr;161(4):1645-55. doi: 10.1104/pp.112.213348. Epub 2013 Feb 15.

23.

Rubisco activity and regulation as targets for crop improvement.

Parry MA, Andralojc PJ, Scales JC, Salvucci ME, Carmo-Silva AE, Alonso H, Whitney SM.

J Exp Bot. 2013 Jan;64(3):717-30. doi: 10.1093/jxb/ers336. Epub 2012 Nov 16. Review.

PMID:
23162118
24.

Protein oligomerization monitored by fluorescence fluctuation spectroscopy: self-assembly of rubisco activase.

Chakraborty M, Kuriata AM, Nathan Henderson J, Salvucci ME, Wachter RM, Levitus M.

Biophys J. 2012 Sep 5;103(5):949-58.

25.

Biophysical characterization of higher plant Rubisco activase.

Henderson JN, Hazra S, Dunkle AM, Salvucci ME, Wachter RM.

Biochim Biophys Acta. 2013 Jan;1834(1):87-97. doi: 10.1016/j.bbapap.2012.09.006. Epub 2012 Sep 14.

PMID:
22985719
26.

Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study.

Efficace F, Baccarani M, Rosti G, Cottone F, Castagnetti F, Breccia M, Alimena G, Iurlo A, Rossi AR, Pardini S, Gherlinzoni F, Salvucci M, Tiribelli M, Vignetti M, Mandelli F.

Br J Cancer. 2012 Sep 4;107(6):904-9. doi: 10.1038/bjc.2012.348. Epub 2012 Aug 7.

27.
28.

Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.

Defina M, Ippoliti M, Gozzetti A, Abruzzese E, Castagnetti F, Crupi R, Tiribelli M, Breccia M, Salvucci M, Aprile L, Baratè C, Gozzini A, Rosti G, Lauria F, Bocchia M.

Cancer. 2012 Nov 1;118(21):5265-9. doi: 10.1002/cncr.27506. Epub 2012 Apr 19.

29.

Rubisco activity is associated with photosynthetic thermotolerance in a wild rice (Oryza meridionalis).

Scafaro AP, Yamori W, Carmo-Silva AE, Salvucci ME, von Caemmerer S, Atwell BJ.

Physiol Plant. 2012 Sep;146(1):99-109. doi: 10.1111/j.1399-3054.2012.01597.x. Epub 2012 Mar 19.

PMID:
22324885
30.

Atomic resolution x-ray structure of the substrate recognition domain of higher plant ribulose-bisphosphate carboxylase/oxygenase (Rubisco) activase.

Henderson JN, Kuriata AM, Fromme R, Salvucci ME, Wachter RM.

J Biol Chem. 2011 Oct 14;286(41):35683-8. doi: 10.1074/jbc.C111.289595. Epub 2011 Aug 31.

31.

The activity of Rubisco's molecular chaperone, Rubisco activase, in leaf extracts.

Carmo-Silva AE, Salvucci ME.

Photosynth Res. 2011 Sep;108(2-3):143-55. doi: 10.1007/s11120-011-9667-8. Epub 2011 Jul 5.

PMID:
21728079
32.

Isolation and compositional analysis of a CP12-associated complex of calvin cycle enzymes from Nicotiana tabacum.

Carmo-Silva AE, Marri L, Sparla F, Salvucci ME.

Protein Pept Lett. 2011 Jun;18(6):618-24.

PMID:
21271977
33.

Insecticidal activity of some reducing sugars against the sweet potato whitefly, Bemisia tabaci, Biotype B.

Hu JS, Gelman DB, Salvucci ME, Chen YP, Blackburn MB.

J Insect Sci. 2010;10:203. doi: 10.1673/031.010.20301.

34.

Raising yield potential of wheat. II. Increasing photosynthetic capacity and efficiency.

Parry MA, Reynolds M, Salvucci ME, Raines C, Andralojc PJ, Zhu XG, Price GD, Condon AG, Furbank RT.

J Exp Bot. 2011 Jan;62(2):453-67. doi: 10.1093/jxb/erq304. Epub 2010 Oct 27. Review.

PMID:
21030385
35.

Rubisco activase activity assays.

Barta C, Carmo-Silva AE, Salvucci ME.

Methods Mol Biol. 2011;684:375-82. doi: 10.1007/978-1-60761-925-3_29.

PMID:
20960144
36.

Purification of Rubisco activase from leaves or after expression in Escherichia coli.

Barta C, Carmo-Silva AE, Salvucci ME.

Methods Mol Biol. 2011;684:363-74. doi: 10.1007/978-1-60761-925-3_28.

PMID:
20960143
37.

Isolation of ribulose-1,5-bisphosphate carboxylase/oxygenase from leaves.

Carmo-Silva AE, Barta C, Salvucci ME.

Methods Mol Biol. 2011;684:339-47. doi: 10.1007/978-1-60761-925-3_26.

PMID:
20960141
38.
39.

Structural changes associated with the acute thermal instability of Rubisco activase.

Barta C, Dunkle AM, Wachter RM, Salvucci ME.

Arch Biochem Biophys. 2010 Jul;499(1-2):17-25. doi: 10.1016/j.abb.2010.04.022. Epub 2010 May 5.

PMID:
20450882
40.

The differential response of photosynthesis to high temperature for a boreal and temperate Populus species relates to differences in Rubisco activation and Rubisco activase properties.

Hozain MI, Salvucci ME, Fokar M, Holaday AS.

Tree Physiol. 2010 Jan;30(1):32-44. doi: 10.1093/treephys/tpp091. Epub 2009 Oct 28.

PMID:
19864261
41.

Association of Rubisco activase with chaperonin-60beta: a possible mechanism for protecting photosynthesis during heat stress.

Salvucci ME.

J Exp Bot. 2008;59(7):1923-33. doi: 10.1093/jxb/erm343. Epub 2008 Mar 18.

PMID:
18353762
42.

Regulation of Rubisco activase and its interaction with Rubisco.

Portis AR Jr, Li C, Wang D, Salvucci ME.

J Exp Bot. 2008;59(7):1597-604. Epub 2007 Nov 29. Review.

PMID:
18048372
43.

Effect of activase level and isoform on the thermotolerance of photosynthesis in Arabidopsis.

Salvucci ME, DeRidder BP, Portis AR Jr.

J Exp Bot. 2006;57(14):3793-9. Epub 2006 Sep 22.

PMID:
16997900
44.

The discovery of Rubisco activase - yet another story of serendipity.

Portis AR Jr, Salvucci ME.

Photosynth Res. 2002;73(1-3):257-64.

PMID:
16245129
45.

Two residues of rubisco activase involved in recognition of the Rubisco substrate.

Li C, Salvucci ME, Portis AR Jr.

J Biol Chem. 2005 Jul 1;280(26):24864-9. Epub 2005 May 2.

47.
48.
49.

Distinct sucrose isomerases catalyze trehalulose synthesis in whiteflies, Bemisia argentifolii, and Erwinia rhapontici.

Salvucci ME.

Comp Biochem Physiol B Biochem Mol Biol. 2003 Jun;135(2):385-95.

PMID:
12798947
50.

Supplemental Content

Loading ...
Support Center